The “Global Pharmaceutical Manufacturing Equipment Market by Equipment Type (Packaging, Mixing & Blending, Filling, Milling, Spray Drying,…
Author: admin
Global Healthcare Business Process Outsourcing (BPO) Market Report 2023: Rise of Nearshore Outsourcing Destinations and Access to Technology Drives Growth
The “Healthcare BPO Market – Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)” report has been added to ResearchAndMarkets.com’s offering. The…
Global Pacemaker Market Report 2023: Increasing Adoption of Cardiac Surgeries Drives Growth
The “Pacemaker Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 &…
Circle Names Heath Tarbert Chief Legal Officer & Head of Corporate Affairs
Today, Circle Internet Financial, a global fintech firm and issuer of USDC,announced that Heath Tarbert has been named chief…
Protalix BioTherapeutics to Host In-Person KOL Breakfast following the Approval of Elfabrio® in both the United States and the European Union for Adults with Fabry Disease
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of…
Global Lactobacillus Acidophilus Probiotics Market to Expand at a CAGR of 8.1% by 2031| Growth Market Reports
According to a recent market study published by Growth Market Reports, titled, “Global Lactobacillus Acidophilus Probiotics…
Breast Cancer Drugs Market to Reach $59.3 Billion, Globally, by 2032 at 8.4% CAGR: Allied Market Research
Allied Market Research published a report, titled, “Breast Cancer Drugs Market by Therapy (Chemotherapy, Hormonal Therapy, Targeted Therapy,…
Global IVD Market Trends Report 2023: IVD Market Remains Dynamic, Demonstrating Constant Innovations
The “IVD Market Trends Report – 2023” report has been added to ResearchAndMarkets.com’s offering. The analyst continues to be diligent…
China Approves the World’s First Vaccine against XBB Descendent Lineages of SARS-CoV-2 for Emergency Use
Coviccine® Trivalent XBB.1.5-Recombinant COVID-19 Trivalent (XBB.1.5+BA.5+Delta) Protein Vaccine (Sf9 cell) developed by WestVac Biopharma/ West China…
Elevation Oncology Announces Pricing of $50 Million Public Offering
Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective…